{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:06:16Z","timestamp":1760144776169,"version":"build-2065373602"},"reference-count":59,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","onlinecjc.ca","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Canadian Journal of Cardiology"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.cjca.2021.08.004","type":"journal-article","created":{"date-parts":[[2021,8,17]],"date-time":"2021-08-17T13:31:13Z","timestamp":1629207073000},"page":"2001-2013","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Process of Care and a Practical Toolkit for Evaluating and Managing Arrhythmic Risk in the Cardiogenetic Pregnant Patient"],"prefix":"10.1016","volume":"37","author":[{"given":"Christopher C.","family":"Cheung","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas M.","family":"Roston","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brianna","family":"Davies","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jasmine","family":"Grewal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zachary W.","family":"Laksman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew D.","family":"Krahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cjca.2021.08.004_bib1","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1161\/CIRCULATIONAHA.109.853143","article-title":"Systematic assessment of patients with unexplained cardiac arrest: Cardiac Arrest Survivors With Preserved Ejection Fraction Registry (CASPER)","volume":"120","author":"Krahn","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2021.08.004_bib2","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1161\/01.CIR.0000015699.48605.08","article-title":"Adverse neonatal and cardiac outcomes are more common in pregnant women with cardiac disease","volume":"105","author":"Siu","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2021.08.004_bib3","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1016\/j.jacc.2018.02.076","article-title":"Pregnancy outcomes in women with heart disease: the CARPREG II study","volume":"71","author":"Silversides","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2021.08.004_bib4","first-page":"452","article-title":"Exercise and inherited arrhythmias","volume":"32","author":"Cheung","year":"2016","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2021.08.004_bib5","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1093\/eurheartj\/ehv371","article-title":"Estradiol regulates human qt-interval: acceleration of cardiac repolarization by enhanced kcnh2 membrane trafficking","volume":"37","author":"Anneken","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2021.08.004_bib6","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/j.jacc.2006.09.054","article-title":"Long QT syndrome and pregnancy","volume":"49","author":"Seth","year":"2007","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2021.08.004_bib7","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1016\/j.jacc.2006.05.060","article-title":"Does pregnancy increase cardiac risk for LQT1 patients with the KCNQ1-A341V mutation?","volume":"48","author":"Heradien","year":"2006","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2021.08.004_bib8","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1136\/heartjnl-2016-310617","article-title":"Arrhythmia risk and beta-blocker therapy in pregnant women with long QT syndrome","volume":"103","author":"Ishibashi","year":"2017","journal-title":"Heart"},{"key":"10.1016\/j.cjca.2021.08.004_bib9","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.hrthm.2004.01.006","article-title":"Identification of a common genetic substrate underlying postpartum cardiac events in congenital long QT syndrome","volume":"1","author":"Khositseth","year":"2004","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.cjca.2021.08.004_bib10","first-page":"CD012859","article-title":"Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis","volume":"10","author":"Weibel","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.cjca.2021.08.004_bib11","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1093\/europace\/euz037","article-title":"Postpartum hormones oxytocin and prolactin cause pro-arrhythmic prolongation of cardiac repolarization in long QT syndrome type 2","volume":"21","author":"Bodi","year":"2019","journal-title":"Europace"},{"key":"10.1016\/j.cjca.2021.08.004_bib12","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.hrthm.2015.09.029","article-title":"Nadolol decreases the incidence and severity of ventricular arrhythmias during exercise stress testing compared with \u03b21-selective \u03b2-blockers in patients with catecholaminergic polymorphic ventricular tachycardia","volume":"13","author":"Leren","year":"2016","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.cjca.2021.08.004_bib13","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1001\/jamacardio.2017.1320","article-title":"Efficacy of flecainide in the treatment of catecholaminergic polymorphic ventricular tachycardia: a randomized clinical trial","volume":"2","author":"Kannankeril","year":"2017","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.cjca.2021.08.004_bib14","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.1093\/eurheartj\/ehz309","article-title":"Implantable cardioverter-defibrillators in previously undiagnosed patients with catecholaminergic polymorphic ventricular tachycardia resuscitated from sudden cardiac arrest","volume":"40","author":"van der Werf","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2021.08.004_bib15","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1016\/j.hrthm.2018.06.046","article-title":"Implantable cardioverter-defibrillator use in catecholaminergic polymorphic ventricular tachycardia: a systematic review","volume":"15","author":"Roston","year":"2018","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.cjca.2021.08.004_bib16","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1007\/s00246-015-1232-3","article-title":"Catecholaminergic ventricular tachycardia, pregnancy and teenager: are they compatible?","volume":"36","author":"Friday","year":"2015","journal-title":"Pediatr Cardiol"},{"key":"10.1016\/j.cjca.2021.08.004_bib17","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.jacep.2018.10.019","article-title":"Pregnancy in catecholaminergic polymorphic ventricular tachycardia","volume":"5","author":"Cheung","year":"2019","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.cjca.2021.08.004_bib18","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1186\/s13256-020-02569-5","article-title":"Catecholaminergic polymorphic ventricular tachycardia in pregnancy: a case report","volume":"14","author":"Schumer","year":"2020","journal-title":"J\u00a0Med Case Rep"},{"key":"10.1016\/j.cjca.2021.08.004_bib19","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.jacep.2018.10.007","article-title":"Challenge and impact of quinidine access in sudden death syndromes: a national experience","volume":"5","author":"Malhi","year":"2019","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.cjca.2021.08.004_bib20","doi-asserted-by":"crossref","first-page":"135","DOI":"10.15420\/aer.2018.21.2","article-title":"Pharmacological therapy in Brugada syndrome","volume":"7","author":"Brodie","year":"2018","journal-title":"Arrhythm Electrophysiol Rev"},{"key":"10.1016\/j.cjca.2021.08.004_bib21","first-page":"176","article-title":"The clinical significance of pregnancy in Brugada syndrome","volume":"67","author":"Rodriguez-Manero","year":"2014","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"key":"10.1016\/j.cjca.2021.08.004_bib22","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1111\/j.1540-8159.2010.02740.x","article-title":"Electrical storm in Brugada syndrome during pregnancy","volume":"34","author":"Sharif-Kazemi","year":"2011","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.cjca.2021.08.004_bib23","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1161\/CIRCEP.115.003220","article-title":"Brugada syndrome phenotype elimination by epicardial substrate ablation","volume":"8","author":"Brugada","year":"2015","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.cjca.2021.08.004_bib24","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehab275","article-title":"Short-coupled ventricular fibrillation represents a distinct phenotype among latent causes of unexplained cardiac arrest: a report from the CASPER registry","author":"Steinberg","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2021.08.004_bib25","doi-asserted-by":"crossref","first-page":"251 e253","DOI":"10.1016\/j.ajem.2010.09.036","article-title":"Isoproterenol as an adjunct for treatment of idiopathic ventricular fibrillation storm in a pregnant woman","volume":"30","author":"Mittadodla","year":"2012","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.cjca.2021.08.004_bib26","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1136\/heartjnl-2018-313476","article-title":"Cardiomyopathy and pregnancy","volume":"105","author":"Schaufelberger","year":"2019","journal-title":"Heart"},{"key":"10.1016\/j.cjca.2021.08.004_bib27","first-page":"e558","article-title":"2020 AHA\/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"142","author":"Ommen","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2021.08.004_bib28","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.1093\/eurheartj\/ehy340","article-title":"2018 esc guidelines for the management of cardiovascular diseases during pregnancy","volume":"39","author":"Regitz-Zagrosek","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2021.08.004_bib29","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/CRD.0000000000000010","article-title":"Pregnancy in women with hypertrophic cardiomyopathy","volume":"22","author":"Schinkel","year":"2014","journal-title":"Cardiol Rev"},{"key":"10.1016\/j.cjca.2021.08.004_bib30","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1055\/s-0038-1676818","article-title":"Hypertrophic cardiomyopathy in patients with atrial fibrillation: prevalence and associated stroke risks in a nationwide cohort study","volume":"119","author":"Jung","year":"2019","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.cjca.2021.08.004_bib31","first-page":"539","article-title":"Switching between \u03b2-blockers: an empiric tool for the cardiovascular practitioner","volume":"35","author":"Roston","year":"2019","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2021.08.004_bib32","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1093\/eurheartj\/eht439","article-title":"A\u00a0novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM RISK-SCD)","volume":"35","author":"O\u2019Mahony","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2021.08.004_bib33","doi-asserted-by":"crossref","first-page":"e301","DOI":"10.1016\/j.hrthm.2019.05.007","article-title":"2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy","volume":"16","author":"Towbin","year":"2019","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.cjca.2021.08.004_bib34","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/pace.12250","article-title":"Combination drug therapy for patients with intractable ventricular tachycardia associated with right ventricular cardiomyopathy","volume":"37","author":"Ermakov","year":"2014","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.cjca.2021.08.004_bib35","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1016\/j.hrthm.2021.04.028","article-title":"Clinical outcomes of catheter ablation of ventricular tachycardia in patients with arrhythmogenic right ventricular cardiomyopathy: insights from the Johns Hopkins ARVC program","volume":"18","author":"Daimee","year":"2021","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.cjca.2021.08.004_bib36","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1136\/heartjnl-2015-308624","article-title":"Pregnancy course and outcomes in women with arrhythmogenic right ventricular cardiomyopathy","volume":"102","author":"Hodes","year":"2016","journal-title":"Heart"},{"key":"10.1016\/j.cjca.2021.08.004_bib37","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.ijcard.2017.11.067","article-title":"Pregnancy and newborn outcomes in arrhythmogenic right ventricular cardiomyopathy\/dysplasia","volume":"258","author":"Gandjbakhch","year":"2018","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.cjca.2021.08.004_bib38","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1093\/eurheartj\/ehz103","article-title":"A\u00a0new prediction model for ventricular arrhythmias in arrhythmogenic right ventricular cardiomyopathy","volume":"40","author":"Cadrin-Tourigny","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2021.08.004_bib39","doi-asserted-by":"crossref","first-page":"665","DOI":"10.7326\/M18-0338","article-title":"\u03b2-Blocker use in pregnancy and the risk for congenital malformations: An international cohort study","volume":"169","author":"Bateman","year":"2018","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cjca.2021.08.004_bib40","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1001\/jamainternmed.2017.0608","article-title":"\u03b2-Bocker exposure in pregnancy and risk of fetal cardiac anomalies","volume":"177","author":"Duan","year":"2017","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.cjca.2021.08.004_bib41","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1016\/j.jacc.2020.03.068","article-title":"Impact of beta-blockers on birth weight in a high-risk cohort of pregnant women with CVD","volume":"75","author":"Grewal","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2021.08.004_bib42","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0895-7061(99)00031-X","article-title":"Atenolol and fetal growth in pregnancies complicated by hypertension","volume":"12","author":"Lydakis","year":"1999","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.cjca.2021.08.004_bib43","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1053\/euhj.2000.2130","article-title":"Treatment of tachyarrhythmias during pregnancy and lactation","volume":"22","author":"Tan","year":"2001","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2021.08.004_bib44","doi-asserted-by":"crossref","first-page":"e41","DOI":"10.1016\/j.hrthm.2016.09.012","article-title":"Beta-blocker therapy for long qt syndrome and catecholaminergic polymorphic ventricular tachycardia: are all beta-blockers equivalent?","volume":"14","author":"Ackerman","year":"2017","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.cjca.2021.08.004_bib45","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1053\/j.semperi.2015.08.003","article-title":"Pharmacokinetics of drugs in pregnancy","volume":"39","author":"Feghali","year":"2015","journal-title":"Semin Perinatol"},{"key":"10.1016\/j.cjca.2021.08.004_bib46","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/0002-9378(88)90491-7","article-title":"Placental transfer of beta-adrenergic antagonists studied in an in\u00a0vitro perfusion system of human placental tissue","volume":"159","author":"Schneider","year":"1988","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.cjca.2021.08.004_bib47","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2016-0731","article-title":"Late pregnancy \u03b2 blocker exposure and risks of neonatal hypoglycemia and bradycardia","volume":"138","author":"Bateman","year":"2016","journal-title":"Pediatrics"},{"key":"10.1016\/j.cjca.2021.08.004_bib48","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1016\/j.hrthm.2013.05.014","article-title":"HRS\/EHRA\/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes: document endorsed by HRS, EHRA, and APHRS in May 2013 and by Accf, AHA, PACES, and Aepc in June 2013","volume":"10","author":"Priori","year":"2013","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.cjca.2021.08.004_bib49","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.hrthm.2019.08.004","article-title":"Caring for the pregnant woman with an inherited arrhythmia syndrome","volume":"17","author":"Roston","year":"2020","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.cjca.2021.08.004_bib50","doi-asserted-by":"crossref","first-page":"e220","DOI":"10.1016\/j.hrthm.2019.02.034","article-title":"2019 HRS\/EHRA\/APHRS\/LAHRS focused update to 2015 expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing","volume":"17","author":"Stiles","year":"2020","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.cjca.2021.08.004_bib51","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1038\/ejhg.2012.285","article-title":"Prenatal diagnostic testing of the noonan syndrome genes in fetuses with abnormal ultrasound findings","volume":"21","author":"Croonen","year":"2013","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.cjca.2021.08.004_bib52","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1053\/j.jvca.2019.07.002","article-title":"Anesthetic management of a patient with type 1 long QT syndrome using combined epidural-spinal anesthesia for caesarean section: perioperative approach based on ion channel function","volume":"34","author":"Hashimoto","year":"2020","journal-title":"J\u00a0Cardiothorac Vasc Anesth"},{"key":"10.1016\/j.cjca.2021.08.004_bib53","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.3109\/14767058.2015.1036023","article-title":"Maternal and neonatal outcomes in labor and at delivery when long qt syndrome is present","volume":"29","author":"Tanaka","year":"2016","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"key":"10.1016\/j.cjca.2021.08.004_bib54","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1213\/ANE.0000000000004712","article-title":"The effect of carbetocin dose on transmural dispersion of myocardial repolarization in healthy parturients scheduled for elective cesarean delivery under spinal anesthesia: a prospective, randomized clinical trial","volume":"132","author":"Clunies-Ross","year":"2021","journal-title":"Anesth Analg"},{"key":"10.1016\/j.cjca.2021.08.004_bib55","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/BF03022321","article-title":"Brief review: anesthetic implications of long QT syndrome in pregnancy","volume":"54","author":"Drake","year":"2007","journal-title":"Can J Anaesth"},{"key":"10.1016\/j.cjca.2021.08.004_bib56","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1161\/CIRCULATIONAHA.120.048250","article-title":"Sex-related differences in cardiac channelopathies: implications for clinical practice","volume":"143","author":"Asatryan","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2021.08.004_bib57","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCGEN.120.003235","article-title":"Variant re-interpretation in survivors of cardiac arrest with preserved ejection fraction (CASPER registry) by clinicians and clinical commercial laboratories","author":"Davies","year":"2021","journal-title":"Circ Genom Precis Med"},{"key":"10.1016\/j.cjca.2021.08.004_bib58","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/j.jacc.2020.01.013","article-title":"Titin truncating variants in adults without known congestive heart failure","volume":"75","author":"Pirruccello","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2021.08.004_bib59","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.cjco.2020.05.006","article-title":"The Hearts in Rhythm organization: a Canadian national cardiogenetics network","volume":"2","author":"Davies","year":"2020","journal-title":"CJC Open"}],"container-title":["Canadian Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X21006474?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X21006474?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:46:50Z","timestamp":1760107610000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0828282X21006474"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":59,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["S0828282X21006474"],"URL":"https:\/\/doi.org\/10.1016\/j.cjca.2021.08.004","relation":{},"ISSN":["0828-282X"],"issn-type":[{"type":"print","value":"0828-282X"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Process of Care and a Practical Toolkit for Evaluating and Managing Arrhythmic Risk in the Cardiogenetic Pregnant Patient","name":"articletitle","label":"Article Title"},{"value":"Canadian Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cjca.2021.08.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}